The U.S. Food and Drug Administration has approved cefadroxil, cefixime, ceftibuten, and azithromycin for once-daily dosing in the treatment of GABHS pharyngitis. The population studied was children with an age
BID dosing of strep tonsillopharyngitisMICHAEL G. BURKE